ALWAZZAN, Ahmad et al. Tumor Marker Heterogeneity in Ovarian Cancer: Clinical Implications of Pretreatment Monitoring of Serum Biomarkers for Recurrence Prediction. World Journal of Oncology, [S. l.], 2026. DOI: 10.14740/wjon2800. Disponível em: https://wjon.elmerpub.com/wjon/article/view/2800.. Acesso em: 24 jul. 2026.